CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sona Nanotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sona Nanotech Inc
Purdy's Wharf Tower 2
1969 Upper Water St Suite 2001
Phone: (902) 442-0653p:902 442-0653 HALIFAX, NS  B3J 3R7  Canada Ticker: SONASONA
Business Summary
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company is developing targeted hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. It is engaged in the development of pre-clinical nanomedical therapy for the treatment of cancer using its proprietary and biocompatible gold nanorods (GNR) leveraging on its core manufacturing technology for these biocompatible GNRs, scientific experience, accumulated study data and laboratory. It has developed multiple proprietary methods for the manufacture of gold nanoparticles which it uses for the development of both cancer therapies and diagnostic testing platforms. Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/202510/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer David A.Regan 53 7/7/2020 7/7/2020
Chief Financial Officer, Corporate Secretary RobertRandall 7/1/2012 7/1/2012
Chief Scientific Officer, Director Len J.Pagliaro 3/23/2023 3/23/2023
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Siva Therapeutics Inc. 5541 Central Avenue. Boulder CO United States

Business Names
Business Name
Siva Therapeutics Inc.
SONA

General Information
Number of Employees: 8 (As of 10/31/2021)
Outstanding Shares: 111,720,361 (As of 1/31/2025)
Stock Exchange: CNQ
Fax Number: (902) 482-1240


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, May 13, 2025